Alyeska Investment Group
RNXT icon

Alyeska Investment Group’s RenovoRx RNXT Stock Holding History

Alyeska Investment Group’s Portfolio RNXT Stock Details RNXT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-688,577
Closed -$682K – 656
2025
Q1 		$682K Buy
+688,577
New +$801K ﹤0.01% 460

Other funds holding RNXT

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
NPT
Nixon Peabody Trust Boston, Massachusetts $1.41B AUM 27.78% 1-Year Est. Return
CCM
Corsair Capital Management New York $800M AUM 94.38% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return

Alyeska Investment Group's RNXT Position: Q2 2025 in Review

Alyeska Investment Group sold out of RenovoRx (RNXT) in Q2 2025, closing a stake of 688,577 shares — an estimated $682K sold.

Alyeska Investment Group first reported a position in RNXT in Q1 2025 and held it in 1 quarter. The position peaked at $682K in Q1 2025. 25 funds tracked by Wall St. Rank hold RNXT as of Q2 2025.

  • Alyeska Investment Group reported no remaining RenovoRx position as of Q2 2025 after selling out during the quarter.
  • Alyeska Investment Group sold 688,577 RenovoRx shares in Q2 2025, an estimated $682K.
  • Alyeska Investment Group first reported a position in RenovoRx in Q1 2025 and held it in 1 quarter.
  • Alyeska Investment Group's RenovoRx position peaked at $682K in Q1 2025.
  • 25 funds tracked by Wall St. Rank held RenovoRx as of Q2 2025.

Based on Alyeska Investment Group's 13F filing for Q2 2025, filed 14 Aug 2025.